Fig. 1From: Delay in treatment intensification increases the risks of cardiovascular events in patients with type 2 diabetesSix-monthly measure of HbA1c (mean and 95% CI) from diagnosis to 2 years, by a patients with and without intensified treatment during follow-up, b by patients receiving treatment intensification before or after 12 months of diagnosis.Back to article page